Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus

NCT ID: NCT00496002

Last Updated: 2009-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Study Classification

INTERVENTIONAL

Study Start Date

2007-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this study are to compare in nucleoside treatment-naïve subjects, the efficacy and safety of clevudine 30 mg once daily versus adefovir 10 mg once daily, each as monotherapy, for 48 weeks and 96 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Hepatitis Hepatitis B

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clevudine

Intervention Type DRUG

Adefovir

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Nucleoside treatment-naïve subjects of either gender, females who are non-pregnant and non-lactating, aged 16 years or older (or the legal age of consent as allowed by local regulations), with compensated hepatic function despite a diagnosis of chronic HBeAg positive hepatitis B infection (i.e., based on serological, virological and histological markers) will be eligible for this study.
* Subjects with historical biopsies used for entry will have chronic hepatic inflammatory injury at screening (Knodell HAI score ≥ 4 and modified Ishak fibrosis score ≤ 5). If applicable, subjects must cease previous treatment with any form of alpha interferon 12 months prior to baseline.
* For eligibility, subjects must meet the laboratory criteria for total bilirubin, prothrombin time, serum albumin, platelet count, absolute neutrophil count, ANA titer and have a creatinine clearance of ≥ 50 mL/min.

Exclusion Criteria

* Subjects participating in a clinical trial or receiving an investigational agent for any reason within 60 days of baseline will be excluded.
* Subjects with clinically significant concomitant diseases will be excluded.
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pharmasset

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

M. Michelle Berrey, MD, MPH

Role: STUDY_DIRECTOR

Pharmasset

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama Birmingham

Birmingham, Alabama, United States

Site Status

Anaheim, California, United States

Site Status

Advanced Clinical Research Institution

Anaheim, California, United States

Site Status

Fresno, California, United States

Site Status

Fresno, California, United States

Site Status

Los Angeles, California, United States

Site Status

Cedars-Sinai Medical Center

Los Angeles, California, United States

Site Status

West Gastroenterology Medical Group

Los Angeles, California, United States

Site Status

Los Angeles, California, United States

Site Status

San Clemente, California, United States

Site Status

San Diego, California, United States

Site Status

Medical Associates Research Group

San Diego, California, United States

Site Status

Sharp Rees-Stealy Medical Group Inc

San Diego, California, United States

Site Status

San Diego, California, United States

Site Status

Quest Clinical Research

San Francisco, California, United States

Site Status

California Pacific Medical Center

San Francisco, California, United States

Site Status

Ucsf/Sfgh

San Francisco, California, United States

Site Status

San Mateo Medical Center

San Mateo, California, United States

Site Status

Norwich, Connecticut, United States

Site Status

The William W. Backus Hospital

Norwich, Connecticut, United States

Site Status

Tampa, Florida, United States

Site Status

Infectious Disease Research Institute, Inc.

Tampa, Florida, United States

Site Status

Tampa, Florida, United States

Site Status

Liver Center

Honolulu, Hawaii, United States

Site Status

Memphis Gastroenterology Group

Germantown, Indiana, United States

Site Status

Iowa Health-Des Moines

Des Moines, Iowa, United States

Site Status

Tulane Medical Center

New Orleans, Louisiana, United States

Site Status

New Orleans, Louisiana, United States

Site Status

Banks Hepatology Institute

College Park, Maryland, United States

Site Status

Boston, Massachusetts, United States

Site Status

Digestive Health Specialists

Tupelo, Mississippi, United States

Site Status

Saint Louis University

St Louis, Missouri, United States

Site Status

Hillsborough, New Jersey, United States

Site Status

UMA Research Department

Binghamton, New York, United States

Site Status

Manhasset, New York, United States

Site Status

Beth Israel Medical Center

New York, New York, United States

Site Status

VAMC/NYU

New York, New York, United States

Site Status

Weill Cornell Medical College

New York, New York, United States

Site Status

New York, New York, United States

Site Status

Asheville, North Carolina, United States

Site Status

Asheville Gastroenterology

Asheville, North Carolina, United States

Site Status

Duke University

Durham, North Carolina, United States

Site Status

Cincinnati, Ohio, United States

Site Status

Cincinnati, Ohio, United States

Site Status

Portland, Oregon, United States

Site Status

Portland, Oregon, United States

Site Status

Oregon Heath and Science University (OHSU)

Portland, Oregon, United States

Site Status

The Oregon Clinica P.C.

Portland, Oregon, United States

Site Status

Nashville Gastrointestinal Specialists, Inc

Nashville, Tennessee, United States

Site Status

Austin, Texas, United States

Site Status

Austin Gastroenterology, PA

Austin, Texas, United States

Site Status

Baylor University Medical Center

Dallas, Texas, United States

Site Status

Methodist Transplant Physicians

Dallas, Texas, United States

Site Status

Galveston, Texas, United States

Site Status

Houston, Texas, United States

Site Status

Advanced Liver Therapies

Houston, Texas, United States

Site Status

Century Clinical Research, Inc.

Houston, Texas, United States

Site Status

Brooke Army Medical Center

San Antonio, Texas, United States

Site Status

Salt Lake City, Utah, United States

Site Status

Salt Lake City, Utah, United States

Site Status

University of Virginia

Charlottesville, Virginia, United States

Site Status

Fairfax, Virginia, United States

Site Status

Metropolitan Research

Fairfax, Virginia, United States

Site Status

Richmond, Virginia, United States

Site Status

Virginia Mason Medical Center

Seattle, Washington, United States

Site Status

Tacoma, Washington, United States

Site Status

Centro De Hepatologia

Buenos Aires, , Argentina

Site Status

Funcei

Buenos Aires, , Argentina

Site Status

Fundacion Favaloro

Buenos Aires, , Argentina

Site Status

Hospital Aleman

Buenos Aires, , Argentina

Site Status

Hospital Britanico de Buenos Aires

Buenos Aires, , Argentina

Site Status

Hospital Universitario Austral

Buenos Aires, , Argentina

Site Status

Sanatorio de la Trinidad Mitre

Buenos Aires, , Argentina

Site Status

Sanatorio Guemes

Buenos Aires, , Argentina

Site Status

Sanatorio Dei Salvador

Córdoba, , Argentina

Site Status

H.I.G.A.O. Alende

Mar del Plata, , Argentina

Site Status

Concord Repatriation General Hospital

Concord, New South Wales, Australia

Site Status

Royal Prince Alfred Hospital

Sydney, New South Wales, Australia

Site Status

Princess Alexandra Hospital

Brisbane, Queensland, Australia

Site Status

Royal Brisbane and Women's Hospital

Brisbane, Queensland, Australia

Site Status

Royal Adelaide Hospital

Adelaide, South Australia, Australia

Site Status

St. Vincent's Health

Fitzroy, Victoria, Australia

Site Status

Western Hospital

Footscray, Victoria, Australia

Site Status

Royal Melbourne Hospital

Melbourne, Victoria, Australia

Site Status

Fremantle Hospital

Fremantle, Western Australia, Australia

Site Status

Royal Perth Hospital

Perth, Western Australia, Australia

Site Status

Intituto A.Z.

Curitiba - PR, Paraná, Brazil

Site Status

University of Rio de Janeiro Medical School Gaffree e Guinie University Hospital

Rio de Janeiro, Rio de Janeiro, Brazil

Site Status

Hospital de Clinicas De Porto Alegre - UFRGS

Porte Alegro, Rio Grande do Sul, Brazil

Site Status

PUC-Campinas

Campinas, São Paulo, Brazil

Site Status

School of Medicine of Ribeirao Preto-University of Sao Paulo

Ribeirão Preto, São Paulo, Brazil

Site Status

Facuidade de Medicina do ABC

Santo André, São Paulo, Brazil

Site Status

Instituto de Ciencias do Hospital Alemao Oswaldo Cruz and Centro de Hepatologia de Sao Paulo

São Paulo, São Paulo, Brazil

Site Status

Instituto de Infectologia Emilio Ribas

São Paulo, São Paulo, Brazil

Site Status

Universidade Federal de Sao Paulo

São Paulo, São Paulo, Brazil

Site Status

NICI Infectologia

Sorocaba, São Paulo, Brazil

Site Status

Santa Casa De Belo Horizonte

Belo Horizonte, , Brazil

Site Status

University of Calgary

Calgary, Alberta, Canada

Site Status

Liver and Intestinal Research Centre (LAIR Centre)

Vancouver, British Columbia, Canada

Site Status

UBC/Downtown ID Clinic

Vancouver, British Columbia, Canada

Site Status

Vancouver, British Columbia, Canada

Site Status

Halifax, Nova Scotia, Canada

Site Status

St. Joseph's Healthcare

Hamilton, Ontario, Canada

Site Status

London, Ontario, Canada

Site Status

Ottawa, Ontario, Canada

Site Status

Toronto, Ontario, Canada

Site Status

The University of Hong Kong

Pok Fu Lam, Hong Kong, China

Site Status

The Chinese University of Hong Kong

Shatin, Hong Kong, China

Site Status

Alice Ho Miu Ling Nethersole Hospital

Tai Po, Hong Kong, China

Site Status

Agios Savvas Hospital

Athens, , Greece

Site Status

Ippokration General Hospital

Athens, , Greece

Site Status

Laiko General Hospital

Athens, , Greece

Site Status

Santurce, , Puerto Rico

Site Status

Fundacion de Investigacion de Diego

Santurce, , Puerto Rico

Site Status

Hospital General Universitario de Alicant

Alicante, , Spain

Site Status

Hospital de la Santa Creu i Sant Pau

Barcelona, , Spain

Site Status

Hospital Vall D'Hebron

Barcelona, , Spain

Site Status

Hospital Clinico San Carlos

Madrid, , Spain

Site Status

Hospital Universitario de La Princesa

Madrid, , Spain

Site Status

Hospital Universitario La Paz

Madrid, , Spain

Site Status

Hospital Universitario Puerta de Hierro

Madrid, , Spain

Site Status

Chang Gung Memorial Hospital Kaosiung

Kaohsiung City, , Taiwan

Site Status

Chung-Ho Memorial Hospital, Kaohsiung Medical University Hospital

Kaohsiung City, , Taiwan

Site Status

Taichung Veterans General Hospital

Taichung, , Taiwan

Site Status

National Cheng Kung University Hospital

Tainan City, , Taiwan

Site Status

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status

Naresuan University

Phitsanulok, Changwat Phitsanulok, Thailand

Site Status

NKC Institute of Gastroenterology and Hepatology/Songklanagarind Hospital

Hat Yai, Changwat Songkhla, Thailand

Site Status

Phramongkutklao Hospital

Bangkok, , Thailand

Site Status

Siriraj Hosptial, Mahidol University

Bangkok, , Thailand

Site Status

Chang Mai University

Chiang Mai, , Thailand

Site Status

Srinagarind Hospital, Khon Kaen University

Khon Kaen, , Thailand

Site Status

Gartnavel General Hospital

Glasgow, , United Kingdom

Site Status

St. George's NHS Trust

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Brazil Canada China Greece Puerto Rico Spain Taiwan Thailand United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CI-PSI-5268-06-305

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Long-term Study With Clevudine
NCT00558818 COMPLETED PHASE4